Ge Ruowen
Corporate Officer/Principal at National University of Singapore
Profile
Ge Ruowen is the founder of ProTherapeutics Pte Ltd, which was founded in 2005.
She held the title of Scientist Officer.
Currently, she is a Principal at the National University of Singapore.
Dr. Ruowen received a doctorate degree from the University of Pennsylvania in 1992.
Ge Ruowen active positions
| Companies | Position | Start |
|---|---|---|
| National University of Singapore | Corporate Officer/Principal | 2010-02-25 |
Former positions of Ge Ruowen
| Companies | Position | End |
|---|---|---|
ProTherapeutics Pte Ltd.
 ProTherapeutics Pte Ltd. BiotechnologyHealth Technology ProTherapeutics Pte Ltd. develops new drugs from proteins. It also offers bioactive peptides, which are derived from snake venom toxins and human proteins for tumor regression, macular degeneration, diabetic retinopathy, anti-hypertension, anti-inflammation, hypolocomotion effect, and clot initiation. The company was founded by Ruowen Ge, Peter Wong Tsun Hon, and R. Manjunatha Kini in April 2005 and is headquartered in Singapore. | Founder | - |
Training of Ge Ruowen
| University of Pennsylvania | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
ProTherapeutics Pte Ltd.
ProTherapeutics Pte Ltd. BiotechnologyHealth Technology ProTherapeutics Pte Ltd. develops new drugs from proteins. It also offers bioactive peptides, which are derived from snake venom toxins and human proteins for tumor regression, macular degeneration, diabetic retinopathy, anti-hypertension, anti-inflammation, hypolocomotion effect, and clot initiation. The company was founded by Ruowen Ge, Peter Wong Tsun Hon, and R. Manjunatha Kini in April 2005 and is headquartered in Singapore. | Health Technology |
- Stock Market
- Insiders
- Ge Ruowen
